Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 adaptive ASP3652 study in female bladder pain syndrome/interstitial cystitis
2011-004555-39Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing ASP3652 with Placebo (2 arms). Primary endpoint: Change from baseline in mean daily pain at week 12. Started Jan 2012; status: completed.
02
Drugs
asp3652
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2011-004555-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004555-39.